Precision Optics (NASDAQ:POCI) Releases Earnings Results

Precision Optics (NASDAQ:POCI) posted its earnings results on Wednesday. The company reported ($0.01) earnings per share for the quarter, FiscalAI reports. Precision Optics had a negative return on equity of 60.56% and a negative net margin of 28.33%.The firm had revenue of $8.71 million for the quarter.

Here are the key takeaways from Precision Optics’ conference call:

• Precision Optics reported a record Q3 revenue of $8.7 million, more than doubling year over year, and achieved positive adjusted EBITDA of $300,000 for the first time in a key milestone quarter.
• The company’s largest production programs continued to drive results, led by the aerospace customer at $3.6 million in revenue and the single-use cystoscope at $2.2 million, both record highs.
• Operational improvements appear to be taking hold, with overall gross margin improving to 23.6% from 2.8% in the prior quarter and 10% a year ago, helped by higher yields, throughput, and cost discipline.
• Management raised fiscal 2026 revenue guidance to $29 million-$31 million and tightened adjusted EBITDA guidance to negative $2.5 million to negative $2.7 million, reflecting improved visibility but still expecting a full-year loss.
• The balance sheet was strengthened by an oversubscribed $10 million public offering, leaving cash at $10.7 million and giving the company more flexibility to support growth and manufacturing investments.

Precision Optics Price Performance

NASDAQ POCI traded up $0.06 during trading on Wednesday, hitting $4.60. 43,785 shares of the company’s stock were exchanged, compared to its average volume of 26,749. The company has a current ratio of 1.05, a quick ratio of 0.62 and a debt-to-equity ratio of 0.11. The company has a market cap of $35.56 million, a PE ratio of -5.00 and a beta of 0.23. Precision Optics has a fifty-two week low of $3.55 and a fifty-two week high of $6.04. The stock’s 50 day moving average price is $4.32 and its two-hundred day moving average price is $4.44.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. DRW Securities LLC bought a new stake in shares of Precision Optics during the fourth quarter worth about $94,000. Needham Investment Management LLC grew its holdings in shares of Precision Optics by 2.9% during the fourth quarter. Needham Investment Management LLC now owns 720,000 shares of the company’s stock worth $3,013,000 after purchasing an additional 20,000 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Precision Optics during the fourth quarter worth about $48,000. Citadel Advisors LLC bought a new stake in shares of Precision Optics during the third quarter worth about $49,000. Finally, WealthTrust Axiom LLC grew its holdings in shares of Precision Optics by 2.7% during the fourth quarter. WealthTrust Axiom LLC now owns 231,808 shares of the company’s stock worth $970,000 after purchasing an additional 6,158 shares during the last quarter. Institutional investors and hedge funds own 13.71% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Precision Optics in a report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Precision Optics Company Profile

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.